Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

COMPLETED
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Description

The objective of this study is to evaluate the safety of long-term treatment with Kuvan.

APPROVED_FOR_MARKETING
Sapropterin Expanded Access Program
Description

The Purpose of this study is to provide patients with hyperphenylalaninemia (HPA) due to Phenylketonuria (PKU) access to sapropterin dihydrochloride and to collect more information about the safety of the drug in an expanded access program (EAP) until commercial product is available.

Conditions